Literature DB >> 12395314

Deletion of the Ron receptor tyrosine kinase domain in mice provides protection from endotoxin-induced acute liver failure.

Mike A Leonis1, Kenya Toney-Earley, Sandra J F Degen, Susan E Waltz.   

Abstract

The targeted deletion of the cytoplasmic domain of the Ron receptor tyrosine kinase (TK) in mice leads to exaggerated responses to injury in several murine models of inflammation as well as increased lethality in response to endotoxin (lipopolysaccharide [LPS]). Using a well-characterized model of LPS-induced acute liver failure (ALF) in galactosamine (GalN)-sensitized mice, we show that Ron TK(-/-) mice display marked protection compared with control Ron TK(+/+) mice. Whereas control mice have profound elevation of serum aminotransferase levels (a marker of hepatocyte injury) and hemorrhagic necrosis of the liver, in dramatic contrast, Ron TK(-/-) mice have mild elevation of aminotransferase levels and relatively normal liver histology. These findings are associated with a reduction in the number of liver cells undergoing apoptosis in Ron TK(-/-) mice. Paradoxically, treatment of Ron TK(-/-) mice with LPS/GalN leads to markedly elevated (3.5-fold) serum levels of tumor necrosis factor (TNF) alpha, a key inflammatory mediator in this liver injury model, as well as reduced amounts of interleukin (IL) 10 (a suppressor of TNF-alpha production) and interferon (IFN)-gamma (a TNF-alpha sensitizer). These results show that ablation of the TK activity of the Ron receptor leads to protection from the development of hepatocellular apoptosis in response to treatment with LPS/GalN, even in the presence of excessive levels of serum TNF-alpha. In conclusion, our studies show that the Ron receptor TK plays a critical role in modulating the response of the liver to endotoxin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395314     DOI: 10.1053/jhep.2002.36822

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  18 in total

1.  Loss of Ron receptor signaling leads to reduced obesity, diabetic phenotypes and hepatic steatosis in response to high-fat diet in mice.

Authors:  William D Stuart; Nicholas E Brown; Andrew M Paluch; Susan E Waltz
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-02-03       Impact factor: 4.310

2.  Ron receptor-dependent gene regulation in a mouse model of endotoxin-induced acute liver failure.

Authors:  Rishikesh M Kulkarni; Louis W Kutcher; William D Stuart; Daniel J Carson; Mike A Leonis; Susan E Waltz
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2012-08-15

3.  Gene expression profiles of Mst1r-deficient mice during nickel-induced acute lung injury.

Authors:  Ali Mallakin; Louis W Kutcher; Susan A McDowell; Sue Kong; Rebecca Schuster; Alex B Lentsch; Bruce J Aronow; George D Leikauf; Susan E Waltz
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09-15       Impact factor: 6.914

4.  The Ron receptor tyrosine kinase regulates acute lung injury and suppresses nuclear factor kappaB activation.

Authors:  Alex B Lentsch; Peterson Pathrose; Sarah Kader; Satoshi Kuboki; Margaret H Collins; Susan E Waltz
Journal:  Shock       Date:  2007-03       Impact factor: 3.454

Review 5.  Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.

Authors:  Purnima K Wagh; Belinda E Peace; Susan E Waltz
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

6.  The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) mice.

Authors:  Sara E Meyer; Susan E Waltz; Kathleen H Goss
Journal:  Mol Carcinog       Date:  2009-11       Impact factor: 4.784

Review 7.  Ron-receptor tyrosine kinase in tumorigenesis and metastasis.

Authors:  Mike A Leonis; Megan N Thobe; Susan E Waltz
Journal:  Future Oncol       Date:  2007-08       Impact factor: 3.404

8.  Ron receptor tyrosine kinase-dependent hepatic neutrophil recruitment and survival benefit in a murine model of bacterial peritonitis.

Authors:  Charles C Caldwell; Andre Martignoni; Mike A Leonis; Hari Kumar Ondiveeran; Alison E Fox-Robichaud; Susan E Waltz
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

9.  HIV-1 Tat mediates degradation of RON receptor tyrosine kinase, a regulator of inflammation.

Authors:  Parisa Kalantari; Omid F Harandi; Pamela A Hankey; Andrew J Henderson
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

10.  Ron receptor tyrosine kinase negatively regulates TNFalpha production in alveolar macrophages by inhibiting NF-kappaB activity and Adam17 production.

Authors:  Nikolaos M Nikolaidis; Jerilyn K Gray; Devikala Gurusamy; William Fox; William D Stuart; Nathan Huber; Susan E Waltz
Journal:  Shock       Date:  2010-02       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.